|
1
|
Kachergus J, Mata IF, Hulihan M, et al:
Identification of a novel LRRK2 mutation linked to autosomal
dominant parkinsonism: evidence of a common founder across European
populations. Am J Hum Genet. 76:672–680. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kay DM, Zabetian CP, Factor SA, et al:
Parkinson's disease and LRRK2: frequency of a common mutation in
U.S. movement disorder clinics. Mov Disord. 21:519–523. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aasly JO, Toft M, FernandezMata I, et al:
Clinical features of LRRK2-associated Parkinson's disease in
central Norway. Ann Neurol. 57:762–765. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gilks WP, AbouSleiman PM, Gandhi S, et al:
A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet.
365:415–416. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gatto EM, Parisi V, Converso DP, et al:
The LRRK2 G2019S mutation in a series of Argentinean patients with
Parkinson's disease: Clinical and demographic characteristic.
Neurosci Lett. 14:1–5. 2013. View Article : Google Scholar
|
|
6
|
Zhang ZX, Anderson DW, Huang JB, et al:
Prevalence of Parkinson's disease and related disorders in the
elderly population of greater Beijing, China. Mov Disord.
7:764–772. 2003. View Article : Google Scholar
|
|
7
|
Paisán-Ruíz C, Jain S, Evans EW, et al:
Cloning of the gene containing mutations that cause PARK8-linked
Parkinson's disease. Neuron. 44:595–600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zimprich A, Biskup S, Leitner P, Lichtner
P, et al: Mutations in LRRK2 cause autosomal-dominant parkinsonism
with pleomorpific pathology. Neuron. 44:601–607. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Funayama M, Hasegawa K, Kowa H, et al: A
new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.
2-q13.1. Ann Neurol. 51:296–301. 2002. View Article : Google Scholar
|
|
10
|
Toft M, Mata IF, Ross OA, Kachergus J, et
al: Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's
disease. Mov Disord. 22:389–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Punia S, Behari M, Govindappa ST,
Swaminath PV, Jayaram S, Goyal V, Muthane UB, Juyal RC and Thelma
BK: Absence/rarity of commonly reported LRRK2 mutations in Indian
Parkinson's disease patients. Neurosci Lett. 409:83–88. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dächsel JC and Farrer MJ: LRRK2 and
Parkinson Disease. Arch Neurol. 67:542–547. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thaler A, Ash E, GanOr Z, OrrUrtreger A
and Giladi N: The LRRK2 G2019S mutation as the cause of Parkinson's
disease in Ashkenazi Jews. J Neural Transm. 116:1473–1482. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thaler A, Mirelman A, Gurevich T, et al:
Lower cognitive performance in healthy G2019S LRRK2 mutation
carriers. Neurology. 79:1027–1032. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Goldwurm S, Zini M, Mariani L, Tesei S,
Miceli R, Sironi F, Clementi M, Bonifati V and Pezzoli G:
Evaluation of LRRK2 G2019S penetrance: relevance for genetic
counselling in Parkinson disease. Neurology. 68:1141–1143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haugarvoll K, Rademakers R, Kachergus JM,
et al: LrrK2 R1441C parkinsonism is clinically similar to sporadic
Parkinson disease. Neurology. 70:1456–1460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Healy DG, Falchi M, O'Sullivan SS,
Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP,
Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR,
Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T,
Bhatia KP, Gasser T, Lees AJ and Wood NW: International LRRK2
Consortium: Phenotype, genotype, and worldwide genetic penetrance
of LRRK2-associated Parkinson's disease: a case-control study.
Lancet Neurol. 7:583–590. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paisán-Ruíz C, Lang AE, Kawari T, et al:
LRRK2 gene in Parkinson disease: Mutation analysis and case control
association study. Neurology. 65:696–700. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taymans JM: The GTPase function of LRRK2.
Biochem Soc Trans. 40:1063–1069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simón-Sánchez J, Schulte C, Bras JM,
Sharma M, et al: Genome-wide association study reveals genetic risk
underlying Parkinson's disease. Nat Genet. 41:1308–1312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Satake W, Nakabayashi Y, Mizuta I, Hirota
Y, Ito C, Kubo M, Kawaguchi T, Tsunoda T, Watanabe M, Takeda A,
Tomiyama H, Nakashima K, Hasegawa K, Obata F, Yoshikawa T, Kawakami
H, Sakoda S, Yamamoto M, Hattori N, Murata M, Nakamura Y and Toda
T: Genome-wide association study identifies common variants at four
loci as genetic risk factors for Parkinson's disease. Nat Genet.
1303–1307. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pankratz N, Beecham GW, DeStefano AL,
Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT,
Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER,
Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM,
Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK and Foroud T:
Meta-analysis of Parkinson's disease: identification of a novel
locus, RIT2. Ann Neurol. 71:370–384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pankratz N, Wilk JB, Latourelle JC,
DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC,
Foroud T and Myers RH: PSG-PROGENI, Gene PD and Investigators,
Coordinators and Molecular Generic Laboratries: Genome wide
association study for susceptibility genes contributing to familial
Parkinson disease. Hum Genet. 124:593–605. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Edwards TL, Scott WK, Almonte C, Burt A,
Powell EH, Beecham GW, Wang L, Züchner S, Konidari I, Wang G,
Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J,
Vance JM and Martin ER: Genome-wide association study confirms SNPs
in SNCA and the MAPT region as common risk factors for Parkinson
disease. Ann Hum Genet. 74:97–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hamza TH, Zabetian CP, Tenesa A, Laederach
A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E,
Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt
J, Factor SA and Payami H: Common genetic variation in the HLA
region is associated with late-onset sporadic Parkinson's disease.
Nat Genet. 42:781–785. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saad M, Lesage S, SaintPierre A, Corvol
JC, Zelenika D, Lambert JC, Vidailhet M, Mellick GD, Lohmann E,
Durif F, Pollak P, Damier P, Tison F, Silburn PA, Tzourio C,
Forlani S, Loriot MA, Giroud M, Helmer C, Portet F, Amouyel P,
Lathrop M, Elbaz A, Durr A, Martinez M and Brice A: French
Parkinson's Disease Genetics Study Group: Genome-wide association
study confirms BST1 and suggests a locus on 12q24 as the risk loci
for Parkinson's disease in the European population. Hum Mol Genet.
20:615–627. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Spencer CC, Plagnol V, Strange A, et al:
Dissection of the genetics of Parkinson's disease identifies an
additional association 5′ of SNCA and multiple associated
haplotypes at 17q21. Hum Mol Genet. 20:345–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nalls MA, Plagnol V, Hernandez DG, Sharma
M, Sheerin UM, Saad M, Simón-Sánchez J, Schulte C, Lesage S,
Sveinbjörnsdóttir S, Stefánsson K, Martinez M, Hardy J, Heutink P,
Brice A, Gasser T, Singleton AB and Wood NW: Imputation of sequence
variants for identification of genetic risks for Parkinson's
disease: a meta-analysis of genome-wide association studies.
Lancet. 377:641–649. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Plagnol V, Nalls MA, Bras JM, et al: A
two-stage meta-analysis identifies several new loci for Parkinson's
disease. PLoS Genet. 7:e10021422011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Do CB, Tung JY, Dorfman E, Kiefer AK,
Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston
JW, Wojcicki A and Eriksson N: Web-based genome-wide association
study identifies two novel loci and a substantial genetic component
for Parkinson's disease. PLoS Genet. 7:e10021412011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Cheng R, Verbitsky M, Kisselev S,
Browne A, MejiaSanatana H, Louis ED, Cote LJ, Andrews H, Waters C,
Ford B, Frucht S, Fahn S, Marder K, Clark LN and Lee JH:
Genome-wide association study identifies candidate genes for
Parkinson's disease in an Ashkenazi Jewish population. BMC Med.
12:1042011.
|
|
32
|
Pihlstrøm L, Axelsson G, Bjørnarå KA,
Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J,
Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E and Toft M:
Supportive evidence for 11 loci from genome-wide association
studies in Parkinson's disease. Neurobiol Aging.
34:1708.e7–1708.e13. 2012. View Article : Google Scholar
|
|
33
|
Sharma M, Ioannidis JP, Aasly JO, et al:
Large-scale replication and heterogeneity in Parkinson disease
genetic loci. Neurology. 79:659–667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martin I, Dawson VL and Dawson TM: The
impact of genetic research on our understanding of Parkinson's
disease. Prog. Brain Res. 183:21–41. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rideout HJ and Stefanis L: The
neurobiology of LRRK2 and its role in the pathogenesis of
Parkinson's disease. Neurochem Res. 39:576–592. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rideout HJ and Stefanis L: The
neurobiology of LRRK2 and its role in the pathogenesis of
Parkinson's disease. Neurochem Res. 39:576–592. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mata IF, Wedemeyer WJ, Farrer MJ, Taylor
JP and Gallo KA: LRRK2 in Parkinson's disease: Protein domains and
functional insights. Trends Neurosci. 29:286–293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Paisán-Ruíz C, Jain S, Evans EW, et al:
Cloning of the gene containing mutations that cause PARK8-linked
Parkinson's disease. Neuron. 44:595–600. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tong Y, Pisani A, Martella G, Karouani M,
Yamaguchi H, Pothos EN and Shen J: R1441C mutation in LRRK2 impairs
dopaminergic neurotransmission in mice. Proc Natl Acad Sci USA.
106:14622–14627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tan EK, Peng R, Teo YY, et al: Multiple
LRRK2 variants modulate risk of Parkinson disease: a Chinese
multicenter study. Hum Mutat. 31:561–568. 2010.PubMed/NCBI
|
|
41
|
Fung HC, Chen CM, Hardy J, et al: Lack of
G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic
Parkinson's disease. Mov Disord. 21:880–881. 2006. View Article : Google Scholar : PubMed/NCBI
|
